ISONIAZID 300mg / RIFAPENTINE, 300mg, break. tab., blister
STD
DORAHRIP33TB1
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
12/04/2024, 17:11:59
Former
Code(s):
DORARIIS33T1 DORAHRIP33T1
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AC51
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
ISONIAZID (H) / RIFAPENTINE (RPT)
Therapeutic Action
Fixed-dose combination (FDC) of two antituberculosis bactericide
Indications
Latent Tuberculosis Infection (LTI-TB)
Instructions for use
For adults and Children > 14 years
Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.
The quantity to be ordered is calculated per tablet, not per blister.
Storage
Below 25°C ‐ Protect from sunlight ‐ Protect from humidity